All In Biotech

Drug Trial Radar · NCT06164431

Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273

Single-dose, Open-label, Randomized, Crossover Bioavailability Study of 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 Under Fasted Condition in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Jan 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Nov 23, 2023

Primary completion

Dec 15, 2023

Study completion Dec 22, 2023

Sponsor

Sponsor type
Industry
First posted
Dec 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish bioavailability of 2 treatments with ZSP1273: 200mg tablets and 200mg granules will be given to healthy Participants under fasting conditions. Bioavailability will be evaluated and verified on the basis of pharmacokinetic data.

Conditions

  • Bioequivalence

Interventions

  • ZSP1273 tabletDrug

    Participants receive ZSP1273 tablet orally.

  • zsp1273 granulesDrug

    Participants receive ZSP1273 granules orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: Day 1 to Day 20
  2. Area under the concentration-time curve from time zero to infinity (AUCinf)Time frame: Day 1 to Day 20
  3. Area under the concentration-time curve from time zero to last time of quantifiable concentration (AUClast)Time frame: Day 1 to Day 20

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Guangdong Hospital of Chinese Medicine

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.